APO Research
Talk to an analyst

APO RESEARCH · REPORT

Apixaban

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Apixaban Market Analysis and Forecast 2026-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchApixaban Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Apixaban Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Apixaban Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Apixaban Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Apixaban Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Apixaban market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Apixaban is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Apixaban is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Apixaban is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Apixaban is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Apixaban include Pfizer, Polpharma, Medichem, Dipharma Francis, DEAFARMA, Centaur Pharmaceutical and Beijing Cooperate Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Apixaban, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Apixaban, also provides the sales of main regions and countries. Of the upcoming market potential for Apixaban, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Apixaban sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Apixaban market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Apixaban sales, projected growth trends, production technology, application and end-user industry.

Apixaban Segment by Company

Pfizer

Polpharma

Medichem

Dipharma Francis

DEAFARMA

Centaur Pharmaceutical

Beijing Cooperate Pharmaceutical

Apixaban Segment by Type

Capsule Apixaban

Tablet Apixaban

Apixaban Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Apixaban Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apixaban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Apixaban and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apixaban.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Apixaban in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Apixaban manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apixaban sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Apixaban Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule Apixaban Major Manufacturers Table 3. Tablet Apixaban Major Manufacturers Table 4. Global Apixaban Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacy Major Manufacturers Table 6. Online Pharmacy Major Manufacturers Table 7. Retail Pharmacy Major Manufacturers Table 8. Apixaban Industry Trends Table 9. Apixaban Industry Drivers Table 10. Apixaban Industry Opportunities and Challenges Table 11. Apixaban Industry Restraints Table 12. Global Apixaban Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Apixaban Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Apixaban Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Apixaban Revenue Market Share by Region (2021-2026) Table 16. Global Apixaban Revenue Market Share by Region (2027-2032) Table 17. Global Apixaban Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Apixaban Sales by Region (2021-2026) & (k units) Table 19. Global Apixaban Sales by Region (2027-2032) & (k units) Table 20. Global Apixaban Sales Market Share by Region (2021-2026) Table 21. Global Apixaban Sales Market Share by Region (2027-2032) Table 22. Global Apixaban Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Apixaban Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Apixaban Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Apixaban Sales Market Share by Manufacturers (2021-2026) Table 26. Global Apixaban Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Apixaban Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Apixaban Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Apixaban Manufacturers, Product Type & Application Table 30. Global Apixaban Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Apixaban by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Apixaban Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Apixaban Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Apixaban Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Apixaban Revenue Market Share by Type (2021-2026) Table 37. Global Apixaban Revenue Market Share by Type (2027-2032) Table 38. Global Apixaban Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Apixaban Sales by Type (2021-2026) & (k units) Table 40. Global Apixaban Sales by Type (2027-2032) & (k units) Table 41. Global Apixaban Sales Market Share by Type (2021-2026) Table 42. Global Apixaban Sales Market Share by Type (2027-2032) Table 43. Global Apixaban Price by Type (2021-2026) & (US$/unit) Table 44. Global Apixaban Price by Type (2027-2032) & (US$/unit) Table 45. Global Apixaban Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Apixaban Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Apixaban Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Apixaban Revenue Market Share by Application (2021-2026) Table 49. Global Apixaban Revenue Market Share by Application (2027-2032) Table 50. Global Apixaban Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Apixaban Sales by Application (2021-2026) & (k units) Table 52. Global Apixaban Sales by Application (2027-2032) & (k units) Table 53. Global Apixaban Sales Market Share by Application (2021-2026) Table 54. Global Apixaban Sales Market Share by Application (2027-2032) Table 55. Global Apixaban Price by Application (2021-2026) & (US$/unit) Table 56. Global Apixaban Price by Application (2027-2032) & (US$/unit) Table 57. Pfizer Company Information Table 58. Pfizer Business Overview Table 59. Pfizer Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Pfizer Apixaban Product Portfolio Table 61. Pfizer Recent Development Table 62. Polpharma Company Information Table 63. Polpharma Business Overview Table 64. Polpharma Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Polpharma Apixaban Product Portfolio Table 66. Polpharma Recent Development Table 67. Medichem Company Information Table 68. Medichem Business Overview Table 69. Medichem Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Medichem Apixaban Product Portfolio Table 71. Medichem Recent Development Table 72. Dipharma Francis Company Information Table 73. Dipharma Francis Business Overview Table 74. Dipharma Francis Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Dipharma Francis Apixaban Product Portfolio Table 76. Dipharma Francis Recent Development Table 77. DEAFARMA Company Information Table 78. DEAFARMA Business Overview Table 79. DEAFARMA Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. DEAFARMA Apixaban Product Portfolio Table 81. DEAFARMA Recent Development Table 82. Centaur Pharmaceutical Company Information Table 83. Centaur Pharmaceutical Business Overview Table 84. Centaur Pharmaceutical Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Centaur Pharmaceutical Apixaban Product Portfolio Table 86. Centaur Pharmaceutical Recent Development Table 87. Beijing Cooperate Pharmaceutical Company Information Table 88. Beijing Cooperate Pharmaceutical Business Overview Table 89. Beijing Cooperate Pharmaceutical Apixaban Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Beijing Cooperate Pharmaceutical Apixaban Product Portfolio Table 91. Beijing Cooperate Pharmaceutical Recent Development Table 92. North America Apixaban Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Apixaban Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Apixaban Sales by Type (2021-2026) & (k units) Table 95. North America Apixaban Sales by Type (2027-2032) & (k units) Table 96. North America Apixaban Sales Price by Type (2021-2026) & (US$/unit) Table 97. North America Apixaban Sales Price by Type (2027-2032) & (US$/unit) Table 98. North America Apixaban Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Apixaban Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Apixaban Sales by Application (2021-2026) & (k units) Table 101. North America Apixaban Sales by Application (2027-2032) & (k units) Table 102. North America Apixaban Sales Price by Application (2021-2026) & (US$/unit) Table 103. North America Apixaban Sales Price by Application (2027-2032) & (US$/unit) Table 104. North America Apixaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Apixaban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Apixaban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Apixaban Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 108. North America Apixaban Sales by Country (2021-2026) & (k units) Table 109. North America Apixaban Sales by Country (2027-2032) & (k units) Table 110. North America Apixaban Sales Price by Country (2021-2026) & (US$/unit) Table 111. North America Apixaban Sales Price by Country (2027-2032) & (US$/unit) Table 112. United States Apixaban Revenue (2021-2032) & (US$ Million) Table 113. Canada Apixaban Revenue (2021-2032) & (US$ Million) Table 114. Mexico Apixaban Revenue (2021-2032) & (US$ Million) Table 115. Europe Apixaban Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Apixaban Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Apixaban Sales by Type (2021-2026) & (k units) Table 118. Europe Apixaban Sales by Type (2027-2032) & (k units) Table 119. Europe Apixaban Sales Price by Type (2021-2026) & (US$/unit) Table 120. Europe Apixaban Sales Price by Type (2027-2032) & (US$/unit) Table 121. Europe Apixaban Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Apixaban Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Apixaban Sales by Application (2021-2026) & (k units) Table 124. Europe Apixaban Sales by Application (2027-2032) & (k units) Table 125. Europe Apixaban Sales Price by Application (2021-2026) & (US$/unit) Table 126. Europe Apixaban Sales Price by Application (2027-2032) & (US$/unit) Table 127. Europe Apixaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Apixaban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Apixaban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Apixaban Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 131. Europe Apixaban Sales by Country (2021-2026) & (k units) Table 132. Europe Apixaban Sales by Country (2027-2032) & (k units) Table 133. Europe Apixaban Sales Price by Country (2021-2026) & (US$/unit) Table 134. Europe Apixaban Sales Price by Country (2027-2032) & (US$/unit) Table 135. Germany Apixaban Revenue (2021-2032) & (US$ Million) Table 136. France Apixaban Revenue (2021-2032) & (US$ Million) Table 137. U.K. Apixaban Revenue (2021-2032) & (US$ Million) Table 138. Italy Apixaban Revenue (2021-2032) & (US$ Million) Table 139. Russia Apixaban Revenue (2021-2032) & (US$ Million) Table 140. Spain Apixaban Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Apixaban Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Apixaban Revenue (2021-2032) & (US$ Million) Table 143. Sweden Apixaban Revenue (2021-2032) & (US$ Million) Table 144. Poland Apixaban Revenue (2021-2032) & (US$ Million) Table 145. China Apixaban Revenue by Type (2021-2026) & (US$ Million) Table 146. China Apixaban Revenue by Type (2027-2032) & (US$ Million) Table 147. China Apixaban Sales by Type (2021-2026) & (k units) Table 148. China Apixaban Sales by Type (2027-2032) & (k units) Table 149. China Apixaban Sales Price by Type (2021-2026) & (US$/unit) Table 150. China Apixaban Sales Price by Type (2027-2032) & (US$/unit) Table 151. China Apixaban Revenue by Application (2021-2026) & (US$ Million) Table 152. China Apixaban Revenue by Application (2027-2032) & (US$ Million) Table 153. China Apixaban Sales by Application (2021-2026) & (k units) Table 154. China Apixaban Sales by Application (2027-2032) & (k units) Table 155. China Apixaban Sales Price by Application (2021-2026) & (US$/unit) Table 156. China Apixaban Sales Price by Application (2027-2032) & (US$/unit) Table 157. Asia Apixaban Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Apixaban Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Apixaban Sales by Type (2021-2026) & (k units) Table 160. Asia Apixaban Sales by Type (2027-2032) & (k units) Table 161. Asia Apixaban Sales Price by Type (2021-2026) & (US$/unit) Table 162. Asia Apixaban Sales Price by Type (2027-2032) & (US$/unit) Table 163. Asia Apixaban Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Apixaban Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Apixaban Sales by Application (2021-2026) & (k units) Table 166. Asia Apixaban Sales by Application (2027-2032) & (k units) Table 167. Asia Apixaban Sales Price by Application (2021-2026) & (US$/unit) Table 168. Asia Apixaban Sales Price by Application (2027-2032) & (US$/unit) Table 169. Asia Apixaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Apixaban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Apixaban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Apixaban Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 173. Asia Apixaban Sales by Country (2021-2026) & (k units) Table 174. Asia Apixaban Sales by Country (2027-2032) & (k units) Table 175. Asia Apixaban Sales Price by Country (2021-2026) & (US$/unit) Table 176. Asia Apixaban Sales Price by Country (2027-2032) & (US$/unit) Table 177. Japan Apixaban Revenue (2021-2032) & (US$ Million) Table 178. South Korea Apixaban Revenue (2021-2032) & (US$ Million) Table 179. India Apixaban Revenue (2021-2032) & (US$ Million) Table 180. Australia Apixaban Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Apixaban Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Apixaban Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Apixaban Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Apixaban Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Apixaban Sales by Type (2021-2026) & (k units) Table 186. SAMEA Apixaban Sales by Type (2027-2032) & (k units) Table 187. SAMEA Apixaban Sales Price by Type (2021-2026) & (US$/unit) Table 188. SAMEA Apixaban Sales Price by Type (2027-2032) & (US$/unit) Table 189. SAMEA Apixaban Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Apixaban Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Apixaban Sales by Application (2021-2026) & (k units) Table 192. SAMEA Apixaban Sales by Application (2027-2032) & (k units) Table 193. SAMEA Apixaban Sales Price by Application (2021-2026) & (US$/unit) Table 194. SAMEA Apixaban Sales Price by Application (2027-2032) & (US$/unit) Table 195. SAMEA Apixaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Apixaban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Apixaban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Apixaban Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 199. SAMEA Apixaban Sales by Country (2021-2026) & (k units) Table 200. SAMEA Apixaban Sales by Country (2027-2032) & (k units) Table 201. SAMEA Apixaban Sales Price by Country (2021-2026) & (US$/unit) Table 202. SAMEA Apixaban Sales Price by Country (2027-2032) & (US$/unit) Table 203. Brazil Apixaban Revenue (2021-2032) & (US$ Million) Table 204. Argentina Apixaban Revenue (2021-2032) & (US$ Million) Table 205. Chile Apixaban Revenue (2021-2032) & (US$ Million) Table 206. Colombia Apixaban Revenue (2021-2032) & (US$ Million) Table 207. Peru Apixaban Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Apixaban Revenue (2021-2032) & (US$ Million) Table 209. Israel Apixaban Revenue (2021-2032) & (US$ Million) Table 210. UAE Apixaban Revenue (2021-2032) & (US$ Million) Table 211. Turkey Apixaban Revenue (2021-2032) & (US$ Million) Table 212. Iran Apixaban Revenue (2021-2032) & (US$ Million) Table 213. Egypt Apixaban Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Apixaban Distributors List Table 217. Apixaban Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Apixaban Image Figure 2. Global Apixaban Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Apixaban Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule Apixaban Image Figure 5. Tablet Apixaban Image Figure 6. Global Apixaban Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Apixaban Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacy Image Figure 9. Online Pharmacy Image Figure 10. Retail Pharmacy Image Figure 11. Global Apixaban Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Apixaban Revenue (2021-2032) & (US$ Million) Figure 13. Global Apixaban Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Apixaban Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Apixaban Revenue Market Share by Region (2021-2032) Figure 16. Global Apixaban Sales (2021-2032) & (k units) Figure 17. Global Apixaban Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Apixaban Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Apixaban Sales YoY (2021-2032) & (k units) Figure 20. Europe Apixaban Sales YoY (2021-2032) & (k units) Figure 21. China Apixaban Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Apixaban Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Apixaban Sales YoY (2021-2032) & (k units) Figure 24. Global Apixaban Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Apixaban Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Apixaban Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Apixaban Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Apixaban Revenue Market Share by Type (2021-2032) Figure 30. Global Apixaban Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Apixaban Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Apixaban Sales Market Share by Type (2021-2032) Figure 33. Global Apixaban Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Apixaban Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Apixaban Revenue Market Share by Application (2021-2032) Figure 36. Global Apixaban Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Apixaban Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Apixaban Sales Market Share by Application (2021-2032) Figure 39. North America Apixaban Revenue Share by Type (2021-2032) Figure 40. North America Apixaban Sales Share by Type (2021-2032) Figure 41. North America Apixaban Revenue Share by Application (2021-2032) Figure 42. North America Apixaban Sales Share by Application (2021-2032) Figure 43. North America Apixaban Revenue Share by Country (2021-2032) Figure 44. North America Apixaban Sales Share by Country (2021-2032) Figure 45. Europe Apixaban Revenue Share by Type (2021-2032) Figure 46. Europe Apixaban Sales Share by Type (2021-2032) Figure 47. Europe Apixaban Revenue Share by Application (2021-2032) Figure 48. Europe Apixaban Sales Share by Application (2021-2032) Figure 49. Europe Apixaban Revenue Share by Country (2021-2032) Figure 50. Europe Apixaban Sales Share by Country (2021-2032) Figure 51. China Apixaban Revenue Share by Type (2021-2032) Figure 52. China Apixaban Sales Share by Type (2021-2032) Figure 53. China Apixaban Revenue Share by Application (2021-2032) Figure 54. China Apixaban Sales Share by Application (2021-2032) Figure 55. Asia Apixaban Revenue Share by Type (2021-2032) Figure 56. Asia Apixaban Sales Share by Type (2021-2032) Figure 57. Asia Apixaban Revenue Share by Application (2021-2032) Figure 58. Asia Apixaban Sales Share by Application (2021-2032) Figure 59. Asia Apixaban Revenue Share by Country (2021-2032) Figure 60. Asia Apixaban Sales Share by Country (2021-2032) Figure 61. SAMEA Apixaban Revenue Share by Type (2021-2032) Figure 62. SAMEA Apixaban Sales Share by Type (2021-2032) Figure 63. SAMEA Apixaban Revenue Share by Application (2021-2032) Figure 64. SAMEA Apixaban Sales Share by Application (2021-2032) Figure 65. SAMEA Apixaban Revenue Share by Country (2021-2032) Figure 66. SAMEA Apixaban Sales Share by Country (2021-2032) Figure 67. Apixaban Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Apixaban Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule Apixaban
  • Tablet Apixaban
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Pfizer
  • Polpharma
  • Medichem
  • Dipharma Francis
  • DEAFARMA
  • Centaur Pharmaceutical
  • Beijing Cooperate Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Apixaban Market by Type
  3. 1.2.1 Global Apixaban Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule Apixaban
  5. 1.2.3 Tablet Apixaban
  6. 1.3 Apixaban Market by Application
  7. 1.3.1 Global Apixaban Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacy
  9. 1.3.3 Online Pharmacy
  10. 1.3.4 Retail Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Apixaban Market Dynamics
  1. 2.1 Apixaban Industry Trends
  2. 2.2 Apixaban Industry Drivers
  3. 2.3 Apixaban Industry Opportunities and Challenges
  4. 2.4 Apixaban Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Apixaban Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Apixaban Revenue by Region
  3. 3.2.1 Global Apixaban Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Apixaban Revenue by Region (2021-2026)
  5. 3.2.3 Global Apixaban Revenue by Region (2027-2032)
  6. 3.2.4 Global Apixaban Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Apixaban Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Apixaban Sales by Region
  9. 3.4.1 Global Apixaban Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Apixaban Sales by Region (2021-2026)
  11. 3.4.3 Global Apixaban Sales by Region (2027-2032)
  12. 3.4.4 Global Apixaban Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Apixaban Revenue by Manufacturers
  2. 4.1.1 Global Apixaban Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Apixaban Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Apixaban Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Apixaban Sales by Manufacturers
  6. 4.2.1 Global Apixaban Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Apixaban Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Apixaban Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Apixaban Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Apixaban Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Apixaban Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Apixaban Manufacturers, Product Type & Application
  13. 4.7 Global Apixaban Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Apixaban Market CR5 and HHI
  16. 4.8.2 2025 Apixaban Tier 1, Tier 2, and Tier 3
5 Apixaban Market by Type
  1. 5.1 Global Apixaban Revenue by Type
  2. 5.1.1 Global Apixaban Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Apixaban Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Apixaban Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Apixaban Sales by Type
  6. 5.2.1 Global Apixaban Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Apixaban Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Apixaban Sales Market Share by Type (2021-2032)
  9. 5.3 Global Apixaban Price by Type
6 Apixaban Market by Application
  1. 6.1 Global Apixaban Revenue by Application
  2. 6.1.1 Global Apixaban Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Apixaban Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Apixaban Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Apixaban Sales by Application
  6. 6.2.1 Global Apixaban Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Apixaban Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Apixaban Sales Market Share by Application (2021-2032)
  9. 6.3 Global Apixaban Price by Application
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Apixaban Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Apixaban Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 Polpharma
  8. 7.2.1 Polpharma Company Information
  9. 7.2.2 Polpharma Business Overview
  10. 7.2.3 Polpharma Apixaban Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Polpharma Apixaban Product Portfolio
  12. 7.2.5 Polpharma Recent Developments
  13. 7.3 Medichem
  14. 7.3.1 Medichem Company Information
  15. 7.3.2 Medichem Business Overview
  16. 7.3.3 Medichem Apixaban Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Medichem Apixaban Product Portfolio
  18. 7.3.5 Medichem Recent Developments
  19. 7.4 Dipharma Francis
  20. 7.4.1 Dipharma Francis Company Information
  21. 7.4.2 Dipharma Francis Business Overview
  22. 7.4.3 Dipharma Francis Apixaban Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Dipharma Francis Apixaban Product Portfolio
  24. 7.4.5 Dipharma Francis Recent Developments
  25. 7.5 DEAFARMA
  26. 7.5.1 DEAFARMA Company Information
  27. 7.5.2 DEAFARMA Business Overview
  28. 7.5.3 DEAFARMA Apixaban Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 DEAFARMA Apixaban Product Portfolio
  30. 7.5.5 DEAFARMA Recent Developments
  31. 7.6 Centaur Pharmaceutical
  32. 7.6.1 Centaur Pharmaceutical Company Information
  33. 7.6.2 Centaur Pharmaceutical Business Overview
  34. 7.6.3 Centaur Pharmaceutical Apixaban Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Centaur Pharmaceutical Apixaban Product Portfolio
  36. 7.6.5 Centaur Pharmaceutical Recent Developments
  37. 7.7 Beijing Cooperate Pharmaceutical
  38. 7.7.1 Beijing Cooperate Pharmaceutical Company Information
  39. 7.7.2 Beijing Cooperate Pharmaceutical Business Overview
  40. 7.7.3 Beijing Cooperate Pharmaceutical Apixaban Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Beijing Cooperate Pharmaceutical Apixaban Product Portfolio
  42. 7.7.5 Beijing Cooperate Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Apixaban Market Size by Type
  2. 8.1.1 North America Apixaban Revenue by Type (2021-2032)
  3. 8.1.2 North America Apixaban Sales by Type (2021-2032)
  4. 8.1.3 North America Apixaban Price by Type (2021-2032)
  5. 8.2 North America Apixaban Market Size by Application
  6. 8.2.1 North America Apixaban Revenue by Application (2021-2032)
  7. 8.2.2 North America Apixaban Sales by Application (2021-2032)
  8. 8.2.3 North America Apixaban Price by Application (2021-2032)
  9. 8.3 North America Apixaban Market Size by Country
  10. 8.3.1 North America Apixaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Apixaban Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Apixaban Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Apixaban Market Size by Type
  2. 9.1.1 Europe Apixaban Revenue by Type (2021-2032)
  3. 9.1.2 Europe Apixaban Sales by Type (2021-2032)
  4. 9.1.3 Europe Apixaban Price by Type (2021-2032)
  5. 9.2 Europe Apixaban Market Size by Application
  6. 9.2.1 Europe Apixaban Revenue by Application (2021-2032)
  7. 9.2.2 Europe Apixaban Sales by Application (2021-2032)
  8. 9.2.3 Europe Apixaban Price by Application (2021-2032)
  9. 9.3 Europe Apixaban Market Size by Country
  10. 9.3.1 Europe Apixaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Apixaban Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Apixaban Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Apixaban Market Size by Type
  2. 10.1.1 China Apixaban Revenue by Type (2021-2032)
  3. 10.1.2 China Apixaban Sales by Type (2021-2032)
  4. 10.1.3 China Apixaban Price by Type (2021-2032)
  5. 10.2 China Apixaban Market Size by Application
  6. 10.2.1 China Apixaban Revenue by Application (2021-2032)
  7. 10.2.2 China Apixaban Sales by Application (2021-2032)
  8. 10.2.3 China Apixaban Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Apixaban Market Size by Type
  2. 11.1.1 Asia Apixaban Revenue by Type (2021-2032)
  3. 11.1.2 Asia Apixaban Sales by Type (2021-2032)
  4. 11.1.3 Asia Apixaban Price by Type (2021-2032)
  5. 11.2 Asia Apixaban Market Size by Application
  6. 11.2.1 Asia Apixaban Revenue by Application (2021-2032)
  7. 11.2.2 Asia Apixaban Sales by Application (2021-2032)
  8. 11.2.3 Asia Apixaban Price by Application (2021-2032)
  9. 11.3 Asia Apixaban Market Size by Country
  10. 11.3.1 Asia Apixaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Apixaban Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Apixaban Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Apixaban Market Size by Type
  2. 12.1.1 SAMEA Apixaban Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Apixaban Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Apixaban Price by Type (2021-2032)
  5. 12.2 SAMEA Apixaban Market Size by Application
  6. 12.2.1 SAMEA Apixaban Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Apixaban Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Apixaban Price by Application (2021-2032)
  9. 12.3 SAMEA Apixaban Market Size by Country
  10. 12.3.1 SAMEA Apixaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Apixaban Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Apixaban Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Apixaban Value Chain Analysis
  2. 13.1.1 Apixaban Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Apixaban Production Mode & Process
  6. 13.2 Apixaban Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Apixaban Distributors
  9. 13.2.3 Apixaban Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst